As of Mar 27
| +1.37 / +0.91%|
The 28 analysts offering 12-month price forecasts for Bayer have a median target of 149.54, with a high estimate of 172.16 and a low estimate of 114.71. The median estimate represents a -2.10% decrease from the last price of 152.75.
The current consensus among 29 polled investment analysts is to Buy stock in Bayer. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.